Santen Pharmaceutical
4536.TTSE PRIMEPharmaceutical
Filed as SANTEN PHARMACEUTICAL CO., LTD. (2022-06–2026-06)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Silchester International Investors LLP | 10.25% |
| Nomura Asset Management Co., Ltd. | 5.26% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 17
| Black Creek Investment Management, Inc. | 3.77% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | 2.82% |
| Amova Asset Management Co., Ltd. | 2.72% |
| - | 2.70% |
| BlackRock Japan Co., Ltd. | 2.03% |
| - | 1.92% |
| BlackRock Institutional Trust Company, N.A. | 1.21% |
| BlackRock Fund Advisors | 1.10% |
| - | 0.61% |
| BlackRock Fund Managers Limited | 0.42% |
| BlackRock Asset Management Ireland Limited | 0.26% |
| BlackRock Advisers, LLC | 0.13% |
| First Sentier Investors RQI Pty Ltd | 0.13% |
| Aperio Group, LLC | 0.11% |
| Nomura Securities Co., Ltd. | 0.06% |
| NOMURA INTERNATIONAL PLC | 0.05% |
| - | 0.03% |
Ownership history · 26
| Holder | Ratio | Change |
|---|---|---|
| Silchester International Investors LLP2024-04-22 · amended | 7.10% | +1.02pp |
| Silchester International Investors LLP2024-04-22 · amended | 6.08% | new |
| -2024-03-18 | 0.03% | new |
| -2024-03-18 | 0.60% | new |
| -2024-03-18 | 1.86% | new |
| -2024-03-18 | 2.70% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.